Search Results - Juki Ng
- Showing 1 - 4 results of 4
-
1
Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis‐Associated Pain: An Application of Markov Model by Insa Winzenborg, Akshanth R. Polepally, Ahmed Nader, Nael M. Mostafa, Peter Noertersheuser, Juki Ng
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Exposure‐Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis‐Associated Pain by Ahmed Abbas Suleiman, Ahmed Nader, Insa Winzenborg, Denise Beck, Akshanth R. Polepally, Juki Ng, Peter Noertersheuser, Nael M. Mostafa
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis by Sven Stodtmann, Ahmed Nader, Akshanth R. Polepally, Ahmed A. Suleiman, Insa Winzenborg, Peter Noertersheuser, Juki Ng, Nael M. Mostafa, Mohamad Shebley
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome by Michael C. Snabes, M.D., Ph.D, Juki Ng, Pharm.D., Ph.D, Hong Li, Ph.D, Izna Ali, Pharm.D., Ph.D, Mohamad Shebley, Ph.D, William D. Schlaff, M.D
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book